This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
JAMA neurology · 2023
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation.
The Journal of pharmacology and experimental therapeutics · 2023
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.
Atherosclerosis · 2022
Latest funding
- $3,456,541
HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)
CIHR · 2020 · Co-investigator
- $654,075
Improving the identification and treatment of young adults with heart disease: the Study to Avoid cardioVascular Events in British Columbia (SAVE BC)
CIHR · 2018 · Principal investigator
- $25,000
Understanding patient priorities in cardiovascular disease prevention research
CIHR · 2016 · Co-investigator
6 publications.
Efficacy and Safety of XEN1101, a Novel Potassium Channel Opener, in Adults With Focal Epilepsy: A Phase 2b Randomized Clinical Trial.
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Pimstone S, Aycardi E, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN, X-TOLE Study Group
Potent, Gut-Restricted Inhibitors of Divalent Metal Transporter 1: Preclinical Efficacy against Iron Overload and Safety Evaluation.
Cutts A, Chowdhury S, Ratkay LG, Eyers M, Young C, Namdari R, Cadieux JA, Chahal N, Grimwood M, Zhang Z, Lin S, Tietjen I, Xie Z, Robinette L, Sojo L, Waldbrook M, Hayden M, Mansour T, Pimstone S, Goldberg YP, Webb M, Cohen CJ
Polygenic architecture and cardiovascular risk of familial combined hyperlipidemia.
Trinder M, Vikulova D, Pimstone S, Mancini GBJ, Brunham LR
TMS as a pharmacodynamic indicator of cortical activity of a novel anti-epileptic drug, XEN1101.
Premoli I, Rossini PG, Goldberg PY, Posadas K, Green L, Yogo N, Pimstone S, Abela E, Beatch GN, Richardson MP
Priorities for Services in Young Patients With Atherosclerotic Cardiovascular Disease and Their Family Members: An Exploratory Mixed-Methods Study.
Cho RY, Weng J, Lynch K, Ng P, Brown C, Hoens AM, Barry K, Brunham LR, Pimstone S
The design and rationale of SAVE BC: The Study to Avoid CardioVascular Events in British Columbia.
Brunham LR, Lynch K, English A, Sutherland R, Weng J, Cho R, Wong GC, Anis AH, Francis GA, Khan NA, McManus B, Wood D, Walley KR, Leipsic J, Humphries KH, Hoens A, Krahn AD, John Mancini GB, Pimstone S
HOST RESPONSE MEDIATORS IN CORONAVIRUS (COVID-19) INFECTION - IS THERE A PROTECTIVE EFFECT OF ARBs ON OUTCOMES OF CORONAVIRUS INFECTION? (ARBs CORONA II)
Principal investigators: Russell, James A
Keywords: Arbs; Biomarkers; Covid-19; Host Response; Losartan; Randomized Controlled Trial
Improving the identification and treatment of young adults with heart disease: the Study to Avoid cardioVascular Events in British Columbia (SAVE BC)
Principal investigators: Brunham, Liam R; Pimstone, Simon
Keywords: Cardiovascular Disease; Cascade Screening; Family History; Genetic Testing; Genetics; Heart Attack; Lipids
Understanding patient priorities in cardiovascular disease prevention research
Principal investigators: Brunham, Liam R; Mancini, G. B. J
Keywords: Atherosclerosis; Cardiovascular Disease; Collaboration; Familial; Genetics; Patient Engagement; Prevention; Training
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Medicine
- Pathology and Laboratory Medicine
- Medical Genetics
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.